In March, the Health and Human Services (HHS) Secretary’s Advisory Committee on Genetics, Health and Society prepared a draft report called “Realizing the Promise of Pharmacogenomics.” The report recommends that the National Institutes of Health make greater allocations to basic research into the biochemistry and genetics involved in drug metabolism, action and effectiveness. In addition, […]
According to a new report from Ernst & Young, the US biotech industry is at its strongest. Deals among US companies reached a total of $23 billion last year, and the value of mergers and acquisitions was at its second-highest level in the industry’s history. Venture capital hit an all-time high of $5.4 billion in […]
Prices of iron ore and nickel reached all-time highs this year, and prices for other key metals have been going strong for five years, driven in part by limited supplies and increased demand from the booming economies of China and India. Copper climbed to its highest price of $4 a pound in 2006, and is […]
According to the National Science Foundation’s latest figures, US R&D spending grew an estimated 6.0% in 2006 to $342.9 billion, compared to 2005 growth of 7.8%. Adjusted for inflation, 2006 real R&D expenditures rose 3.5%, down from growth of 5.0% in 2005. The increase was driven by private sector spending, as real R&D spending by […]
The Pharmaceutical Research and Manufacturers of America’s (PhRMA) “2007 Pharmaceutical Industry Profile” reports that, in 2006, total sales for PhRMA member companies increased 4.2% to $245.8 billion. In 2006, PhRMA member companies spent an estimated $43.0 billion on R&D, a 7.8% increase. R&D as a percentage of sales among member companies in 2006 is estimated […]
The National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), will be granting $23 million a year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance. The Centers of Excellence are located at the following institutions: St. Jude Children’s Hospital, UCLA, the […]
According to the Industrial Research Institute’s (IRI) 23rd annual “R&D Trends Forecast,” R&D spending will increase in 2007. IRI’s R&D index is determined by subtracting the percentage of companies that plan to decrease or maintain their R&D spending from the percentage of companies that plan to increase their spending by at least 5%. This index […]
Sales of semiconductor equipment rose 23.1% last year to $40.47 billion, according to Semiconductor Equipment and Materials International (SEMI). Sales of wafer processing equipment, assembly and packaging equipment, and test equipment increased 26%, 14% and 21%, respectively. Japan, the largest market, accounted for 22.7% of spending, while sales in China, the fastest growing region, increased […]
IMS Health reports that 2006 global pharmaceutical sales grew 7.0% to $643 billion, with “specialist-driven” products accounting for 62% of market growth. Sales in India and China increased 17.5% and 12.3% to $7.3 billion and $13.4 billion, respectively. Latin American sales grew 12.7% to $33.6 billion, and Asian-Pacific and African sales increased 10.5% to $66 […]
Earlier this month, the US Department of Energy (DOE) released its final operating plan for fiscal 2007 (see IBO 2/15/07). The DOE’s budget of $23.598 billion includes $3.8 billion for the Office of Science, a 4.5% increase over the fiscal 2006 appropriation. Within the Office of Science, funding for biological and environmental research decreased 14.3% […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
